infectious diseases
Herpes Zoster
Prevention of Herpes Zoster
A Herpes Zoster Vaccine is recommended for adults ≥ 50 years whether they have had herpes zoster or been given the older, live-attenuated vaccine or not; 2 doses of the recombinant A postmarketing observational study observed an increased risk of Guillain-Barré Syndrome (GBS) during the 42 days following vaccination with the recombinant was about 97% effective at preventing herpes zoster ( Prevention reference ). The live-attenuated vaccine is contraindicated in patients who are immunocompromised. 1.Lal H, Cunningham AL, Godeaux O, et al: Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults.N Engl J Med372(22):2087-96, 2015. Epub 2015 Apr 28. PMID: 25916341. doi: 10.1056/NEJMoa1501184 